Krishna Institute of Medical Sciences Limited (KIMS.BO)
INR 588.6
(0.97%)
INR 588.6
(0.97%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 4.62 Billion | 4.32 Billion | 3.24 Billion | 3.55 Billion | 2.01 Billion | 1.33 Billion |
| Net Income | 3.1 Billion | 4.84 Billion | 4.56 Billion | 2.79 Billion | 1.4 Billion | -153.81 Million |
| Depreciation & Amortization | 1.46 Billion | 1.29 Billion | 726.73 Million | 695.36 Million | 706.1 Million | 564.56 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 154.31 Million | -692.81 Million | -744.68 Million | 141.48 Million | 1.15 Million | -281.23 Million |
| Other non-cash items | 2.8 Billion | -1.12 Billion | -1.31 Billion | -67.25 Million | -97.51 Million | 1.2 Billion |
| Investing Cash Flow | -9.34 Billion | -6.15 Billion | -4.11 Billion | -3.54 Billion | -1.24 Billion | -1.09 Billion |
| Investments in PPE | -6.47 Billion | -5.74 Billion | -1.7 Billion | -944.26 Million | -519.8 Million | -773.49 Million |
| Acquisitions | -1.79 Billion | -2.16 Billion | -3.24 Billion | -352.73 Million | -727.44 Million | -263.99 Million |
| Investment purchases | -3.92 Billion | -5.39 Billion | -5.82 Billion | -2.4 Billion | -170.36 Million | -284.96 Million |
| Sales/Maturities of investments | 2.84 Billion | 7.01 Billion | 6.51 Billion | 113.82 Million | 146.45 Million | 269.43 Million |
| Other Investing Activities | 4.73 Million | 133.63 Million | 137.04 Million | 50.98 Million | 24.04 Million | -44.63 Million |
| Financing Cash Flow | 4.57 Billion | 883.4 Million | 609.99 Million | 98.19 Million | -443.38 Million | -270.39 Million |
| Debt repayment | -5.13 Billion | -2.41 Billion | -2.33 Billion | -1.3 Billion | -715.38 Million | -1.86 Billion |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 1.91 Billion | 950.23 Million | - | 883.1 Million |
| Other Financing Activities | -1.81 Billion | 3.29 Billion | 1.02 Billion | 448.4 Million | 272 Million | 710.29 Million |
| Accounts receivables | -402.91 Million | -628.1 Million | -232.74 Million | 177.46 Million | -132.61 Million | -316.44 Million |
| Accounts payables | 499.42 Million | -410.83 Million | 101.18 Million | 239.2 Million | 134.34 Million | 24.84 Million |
| Inventory | -65.79 Million | 64.7 Million | -123.42 Million | 62.92 Million | -30.48 Million | -57.36 Million |
| Other working capital | 123.59 Million | 281.42 Million | -489.7 Million | -338.1 Million | 29.9 Million | 67.73 Million |
| Cash at beginning of period | 616.11 Million | 256.34 Million | 521.29 Million | 405.14 Million | 80.63 Million | 109.62 Million |
| Cash at end of period | 490.08 Million | 616.11 Million | 256.34 Million | 521.29 Million | 405.14 Million | 80.63 Million |
| Capital Expenditure | -6.47 Billion | -5.74 Billion | -1.7 Billion | -944.26 Million | -519.8 Million | -773.49 Million |
| Effect of forex changes on cash | - | 1.31 Billion | 10 Thousand | - | - | - |
| Net cash flow / Change in cash | -126.03 Million | 359.77 Million | -264.95 Million | 116.15 Million | 324.51 Million | -28.99 Million |
| Free Cash Flow | -1.84 Billion | -1.42 Billion | 1.53 Billion | 2.61 Billion | 1.49 Billion | 565.55 Million |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 866 Million | 654.73 Million | 3.1 Billion | 718.44 Million | 920.16 Million | 808.15 Million |
| Depreciation & Amortization | - | - | 1.46 Billion | 353.76 Million | 326.07 Million | 322.65 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | 154.31 Million | - | - | - |
| Other non-cash items | -866 Million | -654.73 Million | 2.8 Billion | -718.44 Million | -920.16 Million | -808.15 Million |
| Investing Cash Flow | - | - | -9.34 Billion | - | - | - |
| Investments in PPE | - | - | -6.47 Billion | - | - | - |
| Acquisitions | - | - | -1.79 Billion | - | - | - |
| Investment purchases | - | - | -3.92 Billion | - | - | - |
| Sales/Maturities of investments | - | - | 2.84 Billion | - | - | - |
| Other Investing Activities | - | - | 4.73 Million | - | - | - |
| Financing Cash Flow | - | - | 4.57 Billion | - | - | - |
| Debt repayment | - | - | -5.13 Billion | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | -1.81 Billion | - | - | - |
| Accounts receivables | - | - | -402.91 Million | - | - | - |
| Accounts payables | - | - | 499.42 Million | - | - | - |
| Inventory | - | - | -65.79 Million | - | - | - |
| Other working capital | - | - | 123.59 Million | - | - | - |
| Cash at beginning of period | - | - | 616.11 Million | 378.95 Million | -541.21 Million | 616.11 Million |
| Cash at end of period | - | - | 490.08 Million | 718.44 Million | 378.95 Million | 808.15 Million |
| Capital Expenditure | - | - | -6.47 Billion | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | - | -126.03 Million | 339.49 Million | 920.16 Million | 192.04 Million |
| Free Cash Flow | - | - | -1.84 Billion | 718.44 Million | 920.16 Million | 808.15 Million |
BLIBQ
RAJTV
OSUR
TRABI
SHYAMTEL
FMOCF